AVISO IMPORTANTE
Recomendamos que se envíen a RIUMA aquellas publicaciones que vayan a utilizar como aportaciones en próximas convocatorias de solicitud de sexenios, solicitud de complementos o acreditación, ya que NO podemos asegurarle que los envíos que se realicen DURANTE EL PERÍODO DE LA CONVOCATORIA, puedan ser aprobados a tiempo.
Listar por autor "Carretero-Rey, Marta"
Mostrando ítems 1-3 de 3
-
AMPA receptors in synaptic plasticity, memory function, and brain diseases
(Springer Nature, 2025-01-22)Tetrameric AMPA-type ionotropic glutamate receptors are primary transducers of fast excitatory synaptic transmission in the central nervous system, and their properties and abundance at the synaptic surface are crucial ... -
Brain areas interconnected to ventral pathway circuitsare independently able to induce enhancement in objectrecognition memory and cause reversal in object recognitionmemory deficit.
Masmudi-Martin, Mariam; Navarro-Lobato, Irene; López-Aranda, Manuel Francisco; Quirós-Ortega, María Elena; Carretero-Rey, Marta; García-Garrido, María F.; López-Téllez, Juan Félix; Jiménez Recuerda, Inmaculada; Muñoz-de-León-López, Cristina; Khan, Zafaruddin
[et al.] (Wiley, 2024)
Ventral pathway circuits are constituted by the interconnected brain areas that are distributed throughout the brain. These brain circuits are primarily involved in processing of object related information in brain. However, ... -
Promotion of structural plasticity in area V2 of visual cortex prevents against object recognition memory deficits in aging and Alzheimer's disease rodents.
Navarro-Lobato, Irene; Masmudi-Martín, Mariam; López-Aranda, Manuel Francisco; López-Téllez, Juan Félix; Delgado, Gloria; Granados-Durán, Pablo; Gaona-Romero, Celia; Carretero-Rey, Marta; Posadas, Sinforiano; Quirós-Ortega, María Elena; Khan, Zafaruddin[et al.] (Wolters Kluwer Medknow, 2023-11-08)
Memory deficit, which is often associated with aging and many psychiatric, neurological, and neurodegenerative diseases, has been a challenging issue for treatment. Up till now, all potential drug candidates have failed ...